QUESTION: What is the target of Volanesorsen?

IDEAL_ANSWER:
- Volanesorsen is a second-generation antisense oligonucleotide inhibiting apoC-III (apolipoprotein C-III) transcription/translation that has been recently approved in Europe for Familial Chylomicronemia Syndrome (FCS) treatment.

EXACT_ANSWER:
- apoC-III